TRAXV — FIRST TRACKS BIOTHERAPEUTICS, INC. ORDINARY SHARES WHEN-ISSUED (Healthcare >> Biotechnology)
TRAXV FAQ
What is TRAXV's ROE?
FIRST TRACKS BIOTHERAPEUTICS, INC. ORDINARY SHARES WHEN-ISSUED reports a Return on Equity (ROE) of -37.94%.
What is TRAXV's dividend yield?
FIRST TRACKS BIOTHERAPEUTICS, INC. ORDINARY SHARES WHEN-ISSUED offers a dividend yield of 0.00%.
What is TRAXV's Deepscope Quality Score?
Deepscope rates TRAXV's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy TRAXV?
Deepscope's AI Timing Score for TRAXV is 56 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does TRAXV belong to?
FIRST TRACKS BIOTHERAPEUTICS, INC. ORDINARY SHARES WHEN-ISSUED is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 15.84
Price
-0.25
(-1.55%)
Day Change
|
|
|---|
TRAXV, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
44% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 15.84 |
| PBV / Sector |
3.04 / 4.48
|
| Earning Per Share | -1.98 |
| PE / Sector |
N/A / 16.68
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
8.27 M
|
| Average 1W Daily Value |
5.04 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-06-04 09:23:57 |
| Symbol | TRAXV |
| Name | FIRST TRACKS BIOTHERAPEUTICS, INC. ORDINARY SHARES WHEN-ISSUED |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 34.75 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 782.20 / 8,483.11 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 10770 Wateridge Circle, San Diego, CA, United States, 92121
Phone: -
Website: -
Employees: -
Sector: Healthcare >> Biotechnology
Description: First Tracks Biotherapeutics, Inc. operates as a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases. First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was incorporated in 2025 and is headquartered in San Diego, California. First Tracks Biotherapeutics, Inc. operates as a subsidiary of AnaptysBio, Inc.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google